{
    "SPADE_N_14093": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14093",
            "Peptide Name": "SS-I (S. salamandra I; defensins; 3S=S, UCSS1a; natural AMPs; salamanders, amphibians, animals)",
            "Source": "European fire salamander,Salamandra salamandra",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "FVVWGCADYRGSCRTACFAYEYSLGAKGCADGYICCVPNTFRLM",
            "Sequence Length": 44,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antiviral"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 4869.6,
            "PI": 7.76,
            "Hydrophobicity": 0.34,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Barros ALAN, Silva VC, Ribeiro-Junior AF, Cardoso MG, Costa SR, Moraes CB, Barbosa CG, Coleone AP, Simões RP, Cabral WF, Falcão RM, Vasconcelos AG, Rocha JA, Arcanjo DDR, Batagin-Neto A, Borges TKS, Gonçalves J, Brand GD, Freitas-Junior LHG, Eaton P, Marani M, Kato MJ, Plácido A, Leite JRSA.2024",
                    "Reference": "Pharmaceutics. 2024 Jan 29;16(2):190. doi: 10.3390/pharmaceutics16020190.PubMed",
                    "Title": "Antiviral Action against SARS-CoV-2 of a Synthetic Peptide Based on a Novel Defensin Present in the Transcriptome of the Fire Salamander (Salamandra salamandra)."
                }
            ],
            "Frequent Amino Acids": "CAG",
            "Absent Amino Acids": "HOQU",
            "Basic Residues": 4,
            "Acidic Residues": 3,
            "Hydrophobic Residues": 21,
            "Polar Residues": 27,
            "Positive Residues": 4,
            "Negative Residues": 3,
            "Net Charge": 1,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is most similar (75%) toCFBD-1C: 14%.Activity: inhibited SARS-CoV-2 (EC50 2.7 uM). GRAVY: 0.3386; mol Wt: 4869.681; mol formula: C215H318N55O60S7; mol ex coeff: 11885.Toxicity: Vero CCL-81 cells (LC50 10 uM). Little hemolysis till 100 uM.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_26082",
                    "Similarity": 1.0,
                    "Sequence": "FVVWGCADYRGSCRTACFAYEYSLGAKGCADGYICCVPNTFRLM"
                },
                {
                    "SPADE_ID": "SPADE_N_15757",
                    "Similarity": 0.8048780487804879,
                    "Sequence": "FAVWGCADYRGYCRAACFAFEYSLGPKGCTEGYVCCVPNTF"
                }
            ]
        }
    }
}